304646-29-5 Usage
Uses
Used in Pharmaceutical Industry:
2-Methoxy-5-Nitro-4-Pyrimidinamine is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure and reactivity make it a valuable component in the development of new drugs, particularly those targeting infectious diseases, cancer, and other medical conditions.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Methoxy-5-Nitro-4-Pyrimidinamine is utilized as a precursor in the production of pesticides and other agricultural chemicals. Its ability to form stable and effective compounds contributes to the development of innovative solutions for crop protection and pest management.
Used in Organic Synthesis:
2-Methoxy-5-Nitro-4-Pyrimidinamine is also employed as a versatile building block in organic synthesis. Its reactivity and compatibility with various chemical reactions make it a valuable component in the creation of complex organic molecules for a wide range of applications, including the development of new materials, dyes, and other specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 304646-29-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,4,6,4 and 6 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 304646-29:
(8*3)+(7*0)+(6*4)+(5*6)+(4*4)+(3*6)+(2*2)+(1*9)=125
125 % 10 = 5
So 304646-29-5 is a valid CAS Registry Number.
InChI:InChI=1/C5H6N4O3/c1-12-5-7-2-3(9(10)11)4(6)8-5/h2H,1H3,(H2,6,7,8)
304646-29-5Relevant academic research and scientific papers
HINDERED DISULFIDE DRUG CONJUGATES
-
Page/Page column 127; 154; 155, (2017/05/02)
The invention relates generally to disulfide drug conjugates wherein a linker comprising a sulfur-bearing carbon atom substituted with at least one hydrocarbyl or substituted hydrocarbyl is conjugated by a disulfide bond to a cysteine sulfur atom of a targeting carrier, and wherein the linker is further conjugated to a drug moiety. The invention further relates to activated linker-drug conjugates suitable for conjugation to a targeting carrier by a disulfide bond. The invention further relates to methods for preparing hindered disulfide drug conjugates.
Pteridinone derivatives for treating ocular hypertension
-
Page/Page column 5, (2008/06/13)
This invention relates to potent potassium channel blocker compounds of Formula I or a formulation thereof for the treatment of glaucoma and other conditions which lead to elevated intraoccular pressure in the eye of a patient. This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans.
